Hims vs Enhance MD

Side-by-side comparison for weight loss. Both programs operate as US telehealth platforms. We earn affiliate commission from either when you book, disclosed inline on every CTA.

Hims

Hims Weight Loss — compounded GLP-1 from $199/mo

Personalized weight loss kits with compounded GLP-1 medications and provider visits.

Starting price$199/moRating·Reviews·Blocked statesLABest forPeople who want medication plus a wellness ecosystem (coaching, content, app) — not GLP-1 alone.

Pros

· Bundled coaching + medication in one app
· Larger marketing budget = more provider availability
· Free shipping, cancel anytime

Cons

· Bundle pricing can obscure the actual medication cost
· Less specialized than dedicated GLP-1 brands
· Not available in Louisiana

Visit Hims →

We may earn a commission. Price on partner site is final.

Enhance MD

Enhance MD: flat-rate GLP-1 weight-loss care

Prescription semaglutide or tirzepatide via licensed telehealth, one price at every dose.

Starting price$212/moRating·Reviews·Blocked statesAll 50Best forPeople who want predictable flat-rate GLP-1 pricing as the dose increases

Pros

· Flat pricing at every dose, so cost does not jump as you titrate up
· Ongoing provider care and periodic labs included

Cons

· Compounded telehealth program, not a branded FDA-approved product
· Ongoing subscription rather than one-time

Visit Enhance MD →

We may earn a commission. Price on partner site is final.

Which one fits you

Both Hims and Enhance MD are legitimate weight loss programs operating in most US states. The honest answer to "which is better" is "depends." Different patients fit different programs.

· Lower starting price: Hims ($199/mo vs $212/mo)
· More state coverage: Enhance MD (50 states vs 49 states)

How we wrote this comparison

The data is pulled live from our offer database (prices, ratings, state availability, policies). Editorial framing is generated from the field values. We never accept payment for ranking. If Hims pays a higher commission than Enhance MD, it does not appear first on this page. See disclosure.